Abstract: A light emitting sealed body includes a housing which stores a discharge gas in an internal space and is provided with a first window portion to which first light is incident and a second window portion from which second light is emitted. The housing includes at least one flow path which is partitioned from the internal space and extends toward at least one of the first window portion and the second window portion.

Abstract: A light emitting sealed body includes: a housing which stores a discharge gas and is provided with a first opening to which first light is incident along a first optical axis and a second opening from which second light is emitted along a second optical axis; a first window portion which hermetically seals the first opening; and a second window portion which hermetically seals the second opening. The housing is formed of a light shielding material which does not transmit the first light and the second light. An internal space is defined by the housing, the first window portion, and the second window portion and the internal space is filled with the discharge gas. The first opening and the second opening are disposed so that the first optical axis and the second optical axis intersect each other.

Abstract: A medication delivery module is mounted to a patient care device, and a first graphic representative of the first medication delivery module is displayed on a display screen of the device, wherein the first graphic includes an information display area for display of infusion information associated with the first medication delivery module, and a status indicator for display of status information associated with the medication delivery module. Responsive to the indication, the status indicator is dynamically orienting such that the status indicator is displayed on a side of the first graphic nearest the coupling of the first medication delivery module. Infusion information from the first medication delivery module is displayed within the display area of the first graphic.

Abstract: Systems and methods for explaining year over year changes in claim variables are provided. A computing system is configured to receive claim datasets corresponding to one or more time periods, and parse a plurality of claim variables from each claim dataset. The computing system is also configured to cause one or more machine learning models to parse a plurality of explainer values from each of the claim datasets, determine an average explainer value for each of the plurality of explainer values, and determine percent impact values that each correspond to a particular claim variable. The computing system is also configured to generate and render a user interface having one or more selectable features that each represent one of the percent impact values. The computing system is also configured to filter and sort the one or more selectable features based on the percent impact values.

Abstract: A medication delivery module is mounted to a patient care device, and a first graphic representative of the first medication delivery module is displayed on a display screen of the device, wherein the first graphic includes an information display area for display of infusion information associated with the first medication delivery module, and a status indicator for display of status information associated with the medication delivery module. Responsive to the indication, the status indicator is dynamically orienting such that the status indicator is displayed on a side of the first graphic nearest the coupling of the first medication delivery module. Infusion information from the first medication delivery module is displayed within the display area of the first graphic.

Abstract: A medication delivery module is mounted to a patient care device, and a first graphic representative of the first medication delivery module is displayed on a display screen of the device, wherein the first graphic includes an information display area for display of infusion information associated with the first medication delivery module, and a status indicator for display of status information associated with the medication delivery module. Responsive to the indication, the status indicator is dynamically orienting such that the status indicator is displayed on a side of the first graphic nearest the coupling of the first medication delivery module. Infusion information from the first medication delivery module is displayed within the display area of the first graphic.

Abstract: A medication delivery module is mounted to a patient care device, and a first graphic representative of the first medication delivery module is displayed on a display screen of the device, wherein the first graphic includes an information display area for display of infusion information associated with the first medication delivery module, and a status indicator for display of status information associated with the medication delivery module. Responsive to the indication, the status indicator is dynamically orienting such that the status indicator is displayed on a side of the first graphic nearest the coupling of the first medication delivery module. Infusion information from the first medication delivery module is displayed within the display area of the first graphic.

Abstract: A medication delivery module is mounted to a patient care device, and a first graphic representative of the first medication delivery module is displayed on a display screen of the device, wherein the first graphic includes an information display area for display of infusion information associated with the first medication delivery module, and a status indicator for display of status information associated with the medication delivery module. Responsive to the indication, the status indicator is dynamically orienting such that the status indicator is displayed on a side of the first graphic nearest the coupling of the first medication delivery module. Infusion information from the first medication delivery module is displayed within the display area of the first graphic.

Abstract: A method including receiving, in a main frame of a patient care unit, an infusion information from a medication delivery module coupled with the main frame is provided. The medication delivery module being mounted on a plug-in port associated with the main frame. The method also includes displaying, on a display in the main frame, an individual channel card including at least a portion of the infusion information from the medication delivery module and orienting an edge of the individual channel card toward a location of the plug-in port relative to the main frame, the edge having a visual indicator that visually indicates an orientation of the module associated with the individual channel card. The method also includes expanding the individual channel card to display a detailed portion of the infusion information upon receipt of a user selection. A system and a non-transitory, computer readable medium including instructions to perform the above method are also provided.

Abstract: A hydroprocessing catalyst or catalyst precursor has been developed. The catalyst is a unique crystalline ammonia transition metal molybdotungstate material. The hydroprocessing using the crystalline ammonia transition metal molybdotungstate material or a decomposition product thereof may include hydrodenitrification, hydrodesulfurization, hydrodemetallation, hydrodesilication, hydrodearomatization, hydroisomerization, hydrotreating, hydrofining, and hydrocracking.

Abstract: A method including receiving, in a main frame of a patient care unit, an infusion information from a medication delivery module coupled with the main frame is provided. The medication delivery module being mounted on a plug-in port associated with the main frame. The method also includes displaying, on a display in the main frame, an individual channel card including at least a portion of the infusion information from the medication delivery module and orienting an edge of the individual channel card toward a location of the plug-in port relative to the main frame, the edge having a visual indicator that visually indicates an orientation of the module associated with the individual channel card. The method also includes expanding the individual channel card to display a detailed portion of the infusion information upon receipt of a user selection. A system and a non-transitory, computer readable medium including instructions to perform the above method are also provided.

Abstract: A unique crystalline bis-ammonia transition metal molybdotungstate material has been developed. The material may be used as a hydroprocessing catalyst. The hydroprocessing may include hydrodenitrification, hydrodesulfurization, hydrodemetallation, hydrodearomatization, hydrodesilication, hydroisomerization, hydrotreating, hydrofining, and hydrocracking.

Abstract: A hydroprocessing catalyst has been developed. The catalyst is a unique transition metal tungstate material. The hydroprocessing using the crystalline ammonia transition metal dimolybdotungstate material may include hydrodenitrification, hydrodesulfurization, hydrodemetallation, hydrodesilication, hydrodearomatization, hydroisomerization, hydrotreating, hydrofining, and hydrocracking.